From analog bags to phone-free parties, 2025 marked a shift in how much of their time people are willing to spend on the ...

From Roche’s $1.4 billion licensing deal to AstraZeneca’s presidential symposium and an avalanche of clinical readouts, antibody-drug conjugates dominated Europe’s leading cancer conference over the ...

Antibody–drug conjugates (ADCs) in oncology have been some of the most sought-after assets in the biopharma dealmaking landscape in the past two years. For example, in 2023, Pfizer purchased Seagen, ...

While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...

In this tutorial, we will be learning to use an analog to digital converter, or ADC, which communicates to our ESP32 using the SPI serial interface. This file contains hidden or bidirectional Unicode ...

Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...

Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the low ...

Graphics processing units (GPUs), the chips on which most AI models run, are energy-hungry beasts. As a consequence of the accelerating incorporation of GPUs in data centers, AI will drive a 160% ...

Despite some positive trials with new drugs (including immunotherapy) for recurrent cervical cancer, the prognosis for this disease remains poor and additional treatment options are needed. Tisotumab ...

Abstract: MAGICAL is an open-source system for analog and mixed-signal (AMS) circuit layout synthesis. Using custom place-and-route and constraint extraction algorithms, MAGICAL provides a ...